PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Strategies to Improve Quality of Life in Patients With MDS: Translating the Evidence With Oral HMAs to Practice
Visit https://www.peervoice.com/EMC860 to view the entire programme with slides. After completing “Strategies to Improve Quality of Life in Patients With MDS: Translating the Evidence With Oral HMAs to Practice”, participants will be able to: Recognize the disease burden and treatment limitations associated with current standard of care for patients with intermediate- to high-risk myelodysplastic syndromes (MDS); Discuss the clinical evidence with oral formulations of hypomethylating agents (HMAs) for patients with intermediate- to high-risk MDS.